Pro-Dex (PDEX) 10-Q 13 Nov 14 2014 Q1 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
	Sep. 30, 2014	Oct. 28, 2014
Document And Entity Information	'	'
Entity Registrant Name	'PRO DEX INC	'
Entity Central Index Key	'0000788920	'
Document Type	'10-Q	'
Document Period End Date	30-Sep-14	'
Amendment Flag	'false	'
Current Fiscal Year End Date	'--06-30	'
Entity a Well-known Seasoned Issuer	'No	'
Entity a Voluntary Filer	'No	'
Entity's Reporting Status Current	'Yes	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Common Stock, Shares Outstanding	'	4,169,666
Document Fiscal Period Focus	'Q1	'
Document Fiscal Year Focus	'2014	'

CONDENSED_CONSOLIDATED_BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (USD $)	Sep. 30, 2014	Jun. 30, 2014
In Thousands, unless otherwise specified
Current Assets:	'	'
Cash and cash equivalents	$3,609	$3,188
Accounts receivable, net of allowance for doubtful accounts of $34 and $29, respectively	1,094	1,776
Unbilled receivables	1,228	1,073
Other current receivables	20	31
Inventory	2,587	2,600
Prepaid expenses	95	110
Deferred income taxes	115	115
Total current assets	8,748	8,893
Investments	1,082	1,058
Equipment and leasehold improvements, net	1,473	1,575
Intangibles	165	105
Other assets	77	77
Total assets	11,545	11,708
Current Liabilities:	'	'
Accounts payable	617	744
Accrued expenses	1,211	1,090
Deferred revenue	247	232
Income taxes payable	48	53
Capital lease obligations	9	8
Total current liabilities	2,132	2,127
Deferred income taxes	115	115
Deferred rent	232	243
Capital lease obligations, net of current portion	4	7
Total non-current liabilities	351	365
Total liabilities	2,483	2,492
Shareholders' equity:	'	'
Common shares; no par value; 50,000,000 shares authorized; 4,203,354 and 4,211,019 shares issued and outstanding at September 30, 2014 and June 30, 2014, respectively	18,587	18,582
Accumulated other comprehensive income	213	202
Accumulated deficit	-9,738	-9,568
Total shareholders' equity	9,062	9,216
Total liabilities and shareholders' equity	$11,545	$11,708

CONSOLIDATED_BALANCE_SHEETS_Un

CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) (USD $)	Sep. 30, 2014	Jun. 30, 2014
In Thousands, except Share data, unless otherwise specified
Statement of Financial Position [Abstract]	'	'
Accounts receivable, allowance for doubtful accounts (in dolllars)	$34	$29
Common shares, par value (in dollars per share)	$0	$0
Common shares, shares authorized	50,000,000	50,000,000
Common shares, shares issued	4,203,354	4,211,019
Common shares, shares outstanding	4,203,354	4,211,019

CONDENSED_CONSOLIDATED_STATEME

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (USD $)	3 Months Ended
In Thousands, except Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013
Income Statement [Abstract]	'	'
Net sales	$2,595	$2,555
Cost of sales	1,767	1,610
Gross profit	828	945
Operating expenses:	'	'
Selling expenses	142	92
General and administrative expenses	491	457
Research and development costs	384	375
Total operating expenses	1,017	924
Operating income (loss)	-189	21
Other income (expense):	'	'
Interest income	1	'
Interest expense	-2	-2
Total other income (expense)	-1	-2
Income (loss) from continuing operations before income taxes	-190	19
Provision (benefit) for income taxes	-9	1
Income (loss) from continuing operations	-181	18
Income from discontinued operations, net of income taxes	11	194
Net income (loss)	-170	212
Other comprehensive income, net of tax:	'	'
Unrealized gain from marketable equity investments	12	56
Comprehensive income (loss)	($158)	$268
Basic and diluted income (loss) per share:	'	'
Net income (loss) from continuing operations (in dollars per share)	($0.04)	$0
Income from discontinued operations (in dollars per share)	$0	$0.06
Net income (loss) (in dollars per share)	($0.04)	$0.06
Weighted average common shares outstanding - basic (in shares)	4,208,957	3,344,697
Weighted average common shares outstanding - diluted (in shares)	4,227,650	3,353,447

CONDENSED_CONSOLIDATED_STATEME1

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013
CASH FLOWS FROM OPERATING ACTIVITIES:	'	'
Net income (loss)	($170)	$212
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:	'	'
Depreciation and amortization	127	132
Gain on sale of real estate held for sale	'	-167
Share-based compensation	8	20
Allowance for doubtful accounts	5	3
Changes in operating assets and liabilities:	'	'
Accounts receivable and other receivables	688	-8
Unbilled receivables	-155	-154
Inventory	13	-139
Prepaid expenses and other assets	15	18
Accounts payable, accrued expenses and deferred rent	-18	-500
Deferred revenue	15	71
Income taxes payable	-5	'
Net cash provided by (used in) operating activities	523	-512
CASH FLOWS FROM INVESTING ACTIVITIES:	'	'
Purchases of equipment	-25	'
Proceeds from sale of real estate held for sale	'	900
Proceeds from sale of equipment	'	6
Increase in intangibles	-60	-17
Purchase of investments	-12	-228
Net cash provided by (used in) investing activities	-97	661
CASH FLOWS FROM FINANCING ACTIVITIES:	'	'
Principal payments on capital lease	-2	'
Payments made for common stock rights offering costs	-3	'
Net cash used in financing activities	-5	'
Net increase in cash and cash equivalents	421	149
Cash and cash equivalents, beginning of period	3,188	1,680
Cash and cash equivalents, end of period	3,609	1,829
Supplemental disclosures of cash flow information:	'	'
Cash paid for interest	2	2
Cash paid for income taxes	$8	'

BASIS_OF_PRESENTATION

BASIS OF PRESENTATION	3 Months Ended
	Sep. 30, 2014
Accounting Policies [Abstract]	'
BASIS OF PRESENTATION	'
	NOTE 1. BASIS OF PRESENTATION
	The accompanying unaudited condensed consolidated financial statements of Pro-Dex, Inc. (“we”, “us”, “our”, “Pro-Dex” or the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Regulation S-K. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. These financial statements should be read in conjunction with the consolidated financial statements presented in our Annual Report on Form 10-K for the fiscal year ended June 30, 2014. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. The results of operations for such interim periods are not necessarily indicative of the results that may be expected for the full year. For further information, refer to the consolidated financial statements and footnotes thereto included in our Annual Report on Form 10-K for the year ended June 30, 2014.
	Recent Accounting Standards
	In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2014-09, “Revenue from Contracts with Customers,” which outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. ASU 2014-09 requires an entity to recognize revenue depicting the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. ASU 2014-09 also requires enhanced revenue related disclosures. ASU 2014-09 is effective for fiscal years, and interim reporting periods within those years, beginning after December 15, 2016. The Company has not yet determined the impact of ASU 2014-09 on its consolidated results of operations, financial condition, or cash flows.
	In April 2014, the FASB issued ASU 2014-08, “Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity.” ASU 2014-08 requires that a disposal representing a strategic shift that has (or will have) a major effect on an entity’s financial results or a business activity classified as held for sale should be reported as discontinued operations. ASU 2014-08 also expands the disclosure requirements for discontinued operations and adds new disclosures for individually significant dispositions that do not qualify as discontinued operations. ASU 2014-08 is effective prospectively for fiscal years, and interim reporting periods within those years, beginning after December 15, 2014. The impact of ASU 2014-08 is dependent upon the nature of dispositions, if any, after adoption.
	Reclassifications
	Certain prior period balances have been reclassified to conform to the current period presentation. The reclassifications have no effect on previously reported results of operations or accumulated deficit.

COMPOSITION_OF_CERTAIN_FINANCI

COMPOSITION OF CERTAIN FINANCIAL STATEMENT ITEMS	3 Months Ended
	Sep. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
COMPOSITION OF CERTAIN FINANCIAL STATEMENT ITEMS	'
	NOTE 2. COMPOSITION OF CERTAIN FINANCIAL STATEMENT ITEMS
	Inventory
	Inventory is stated at the lower of cost (first-in, first-out) or market and consists of the following (in thousands):
		September 30,		June 30,
		2014		2014
	Raw materials /purchased components	$	820	$	878
	Work in process		750		525
	Sub-assemblies /finished components		801		823
	Finished goods		216		374
	Total inventory	$	2,587	$	2,600
	Investments
	Investments are stated at market value and consist of the following (in thousands):
		September 30,		June 30,
		2014		2014
	Marketable equity securities	$	1,082	$	1,058
	Investments at September 30, 2014 and June 30, 2014 had an aggregate cost basis of $869,000 and $857,000, respectively, gross unrealized gains aggregating $231,000 and $208,000, respectively, and unrealized losses of 18,000 and $7,000, respectively.
	Intangibles
	Intangibles consist of the following (in thousands):
		September 30,		June 30,
		2014		2014
	Capitalized software development costs	$	73	$	37
	Patent-related costs		92		68
	Total intangibles	$	165	$	105
	Capitalized software development costs relate to internally developed software, which will be amortized over the estimated product life of the underlying product currently in development. Patent-related costs consist of legal fees incurred in connection with patent applications, and will be amortized over the life of the applicable patent upon its issuance.

WARRANTY

WARRANTY	3 Months Ended
	Sep. 30, 2014
Product Warranties Disclosures [Abstract]	'
WARRANTY	'
	NOTE 3. WARRANTY
	The warranty accrual is based on historical costs of warranty repairs and expected future identifiable warranty expenses, and is included in accrued expenses in the accompanying consolidated balance sheets. As of September 30, 2014 and June 30, 2014, the warranty reserve amounted to $213,000 and $237,000, respectively. Warranty expenses are included in cost of sales in the accompanying consolidated statements of operations. Changes in estimates to previously established warranty accruals result from current period updates to assumptions regarding repair costs and warranty return rates, and are included in current period warranty expense. Total warranty expense for the three months ended September 30, 2014 and 2013 was ($5,000) and $13,000, respectively.
	Information regarding the accrual for warranty costs for the three months ended September 30, 2014 and 2013 are as follows (in thousands):
		As of and for the
		Three Months Ended
		September 30,
		2014			2013
	Beginning balance	$	237		$	321
	Accruals during the period		70			49
	Changes in estimates of prior period warranty accruals		(75	)		(36	)
	Warranty amortization		(19	)		(105	)
	Ending balance	$	213		$	229

NET_INCOME_LOSS_PER_SHARE

NET INCOME (LOSS) PER SHARE	3 Months Ended
	Sep. 30, 2014
Earnings Per Share [Abstract]	'
NET INCOME (LOSS) PER SHARE	'
	NOTE 4. NET INCOME (LOSS) PER SHARE
	The Company calculates basic net earnings (loss) per share by dividing net income (loss) by the weighted-average number of common shares outstanding during the reporting period. Diluted earnings (loss) per share reflects the effects of potentially dilutive securities, which consist entirely of outstanding stock options.
	Potential common shares of 18,693 have been excluded from diluted weighted average common shares for the three months ended September 30, 2014, as the effect would have been anti-dilutive. The following table presents reconciliations of the numerators and denominators of the basic and diluted earnings (loss) per share computations for net income (loss). In the tables below, income (loss) amounts represent the numerator, and share amounts represent the denominator (in thousands, except per share amounts):
		Three Months Ended
		September 30,
		2014			2013
	Basic:
	Income (loss) from continuing operations	$	(181	)	$	18
	Weighted average shares outstanding		4,209			3,345
	Basic income (loss) per share from continuing operations	$	(0.04	)	$	0
	Income from discontinued operations	$	11		$	194
	Weighted average shares outstanding		4,209			3,345
	Basic income (loss) per share from discontinued operations	$	0		$	0.06
	Net income (loss)	$	(170	)	$	212
	Weighted average shares outstanding		4,209			3,345
	Basic income (loss) per share	$	(0.04	)	$	0.06
	Diluted:
	Income (loss) from continuing operations	$	(181	)	$	18
	Weighted average shares outstanding		4,209			3,345
	Effect of dilutive securities – stock options		—			8
	Weighted average shares used in calculation of diluted earnings per share		4,209			3,353
	Basic and diluted loss per share from continuing operations	$	(0.04	)	$	0
	Income from discontinued operations	$	11		$	194
	Weighted average shares outstanding		4,209			3,345
	Effect of dilutive securities – stock options		—			8
	Weighted average shares used in calculation of diluted earnings per share		4,209			3,353
	Diluted income per share from discontinued operations	$	0		$	0.06
	Net income (loss)	$	(170	)	$	212
	Weighted average shares used in calculation of diluted earnings per share		4,209			3,353
	Diluted earnings (loss) per share	$	(0.04	)	$	0.06

DISCONTINUED_OPERATIONS_AND_RE

DISCONTINUED OPERATIONS AND REAL ESTATE HELD FOR SALE	3 Months Ended
	Sep. 30, 2014
Notes to Financial Statements	'
DISCONTINUED OPERATIONS AND REAL ESTATE HELD FOR SALE	'
	NOTE 5. DISCONTINUED OPERATIONS AND REAL ESTATE HELD FOR SALE
	In February 2012, we completed the sale of our fractional horsepower motor product line, operating under the name Pro-Dex Astromec (“Astromec”) and located in Carson City, Nevada, to SL Montevideo Technology, Inc. (“MTI”), a wholly owned subsidiary of SL Industries, Inc., pursuant to an Asset Purchase Agreement (the “APA”).
	Under the terms of the APA, we may receive earnout payments based on revenues generated from the sale of (i) Astromec products and (ii) MTI products to Astromec prospects (defined in the APA) (collectively, the “Earnout Sales Base”). Such earnout payments, if and when earned, are paid by MTI to us within 30 days following the end of each of our fiscal quarters during the three years subsequent to the February 2012 closing date, and amount to 6%, 4% and 2% of the Earnout Sales Base in the first, second and third such years, respectively. The earnout payments are recognized in the quarter in which we become entitled to receive them. We recognized income from earnout payments of $21,000 and $29,000 for the three months ended September 30, 2014 and 2013, respectively, and have recognized an aggregate of $372,000 in income from such earnout payments since the February 2012 closing date.
	In addition, as a result of the sale of the Astromec product line, we listed for sale the land and building constituting the facility in Carson City, Nevada, which was presented as real estate held for sale in the June 30, 2013 consolidated balance sheet with an aggregate carrying amount of $733,000. On July 5, 2013, we completed the sale of the Carson City facility to Aesthetic and Reconstructive Technologies, Inc., a Nevada corporation. The sales price of the property was $980,000, of which we received net proceeds of $900,000, after deductions for expenses related to the sale, primarily consisting of broker commissions and fees, aggregating approximately $80,000, resulting in a gain of $167,000.
	Based on the foregoing, and in conformity with applicable accounting guidance, the Astromec product line qualifies as a discontinued operation. Accordingly, financial results of Astromec have been reported as discontinued operations in the accompanying consolidated statements of operations for all periods presented. Information regarding revenue and operating results of Astromec included in discontinued operations is as follows (in thousands):
		Three Months Ended
		September 30,
		2014		2013
	Revenues	$	21	$	29
	Income before provision for income taxes of $7,000 and $0, respectively	$	18	$	194
	Information regarding Astromec assets and liabilities included in the accompanying consolidated balance sheets is as follows (in thousands):
		September 30,		June 30,
		2014		2014
	Accounts receivable	$	21	$	17
	Prepaid expenses	$	—	$	3
	Accrued expenses	$	2	$	2

INCOME_TAXES

INCOME TAXES	3 Months Ended
	Sep. 30, 2014
Income Tax Disclosure [Abstract]	'
INCOME TAXES	'
	NOTE 6. INCOME TAXES
	Deferred income taxes are provided on a liability method whereby deferred tax assets and liabilities are recognized for temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.
	Significant management judgment is required in determining our provision for income taxes and the recoverability of our deferred tax assets. Such determination is based primarily on our historical taxable income or loss, with some consideration given to our estimates of future taxable income or loss by jurisdictions in which we operate and the period over which our deferred tax assets would be recoverable. Due to cumulative taxable losses during the past three years, we maintained a valuation allowance of $3.5 million against our deferred tax assets as of June 30, 2014.
	As of September 30, 2014, we have accrued $366,000 of unrecognized tax benefits related to federal and state income tax matters. The amount that would reduce the Company’s income tax expense if recognized and result in a corresponding decrease in the Company’s effective tax rate is $47,000.
	A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows (in thousands):
	Balance at July 1, 2014	$	363
	Additions based on tax positions related to the current year		3
	Balance at September 30, 2014	$	366
	We recognize accrued interest and penalties related to unrecognized tax benefits when applicable. As of September 30, 2014, no interest or penalties applicable to our unrecognized tax benefits have been accrued since we have sufficient tax attributes available to fully offset any potential assessment of additional tax.
	The Company and its subsidiaries are subject to U.S. federal income tax, as well as income tax of multiple state tax jurisdictions. We are currently open to audit under the statute of limitations by the Internal Revenue Service for the years ended June 30, 2011 and later. Our state income tax returns are open to audit under the statute of limitations for the years ended June 30, 2010 and later. We do not anticipate a significant change to the total amount of unrecognized tax benefits within the next 12 months.

COMMON_STOCK

COMMON STOCK	3 Months Ended
	Sep. 30, 2014
Equity [Abstract]	'
COMMON STOCK	'
	NOTE 7. COMMON STOCK
	Rights Offering
	On December 17, 2013, we publicly announced plans to complete a rights offering to existing holders of our common stock, and we commenced the rights offering on March 24, 2014, pursuant to a registration statement on Form S-3 filed with the Securities and Exchange Commission (“SEC’). The rights offering was made through the distribution to our existing shareholders as of March 20, 2014 of non-transferable subscription rights to purchase their pro rata portion of newly issued shares of our common stock (the “Subscription Privilege”) at a price of $1.90 per share (the “Subscription Price”). The subscription period for exercise of the rights commenced on March 24, 2014 and expired on April 25, 2014.
	Upon completion of the rights offering, we received gross proceeds of approximately $1.65 million, before expenses of $140,000, through shareholder subscriptions for 868,732 shares of common stock.
	Of the total amount of shares issued, 317,231 and 156,189 shares were issued to AO Partners I, LP (“AO Partners”) and Farnam Street Partners, L.P. (“Farnam Street Partners”), respectively, the Company’s two largest shareholders, who each exercised its full pro-rata allotment of rights in the offering. AO Partners, LLC is the General Partner of AO Partners, and Nicholas J. Swenson, a director of the Company, is the Managing Member of AO Partners, LLC. Raymond E. Cabillot, also a director of the Company, is the CEO of Farnam Street Partners.
	In connection with the rights offering, we entered into a Standby Purchase Agreement with AO Partners, LLC and Farnam Street Capital, Inc. (each a beneficial shareholder of our common stock; each a “Standby Purchaser” and collectively the “Standby Purchasers”) pursuant to which the Standby Purchasers agreed to purchase, at the Subscription Price, any and all shares of common stock not subscribed for by shareholders in connection with the rights offering, subject to reduction by us as described below. No fees or other consideration were paid by us to the Standby Purchasers in exchange for their commitment to purchase any and all unsubscribed shares of common stock following the rights offering.
	In the event that the exercise by a shareholder of the Subscription Privilege or the purchase of our common stock under the Standby Purchase Agreement could, in our sole discretion, have potentially resulted in a limitation of our ability to utilize our tax attributes, such as the annual utilization of net operating loss or tax credit carry forwards (see Note 6), we had the ability to reduce the exercise by such shareholder of the Subscription Privilege or the amount purchased under the Standby Purchase Agreement to such number of shares of our common stock as we determined advisable in order to preserve our ability to utilize such tax attributes. On the basis of the Company’s analysis of tax attributes, the Company did not reduce the subscriptions of any shareholder in the rights offering, but did reduce to zero the number of shares the Standby Purchasers could have otherwise purchased pursuant to the Standby Purchase Agreement. As a result, no shares were issued to AO Partners, LLC or Farnam Street Capital, Inc. pursuant to the Standby Purchase Agreement.
	We intend to use the net proceeds of the rights offering to pursue strategic opportunities that may present themselves from time to time or, if not used to pursue strategic opportunities, for working capital and general corporate purposes, including to fund ongoing research and development and product initiatives. Also, to the extent the net proceeds are not deployed, some of the funds may be invested in accordance with the terms of our Surplus Capital Investment Policy.
	Share Repurchase Program
	In September 2013, our Board approved a share repurchase program authorizing the Company to repurchase up to 750,000 shares of our common stock. In accordance with, and as part of, this share repurchase program, our Board approved, on September 23, 2014, the adoption of a prearranged share repurchase plan intended to qualify for the safe harbor under Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (“10b5-1 Plan”). The 10b5-1 Plan became effective on September 24, 2014 and terminates on March 23, 2015, unless terminated sooner in accordance with its terms. Through September 30, 2014, we repurchased 7,665 shares at an aggregate cost of $17,000 under the terms of the 10b5-1 Plan, which purchases settled in October, 2014. Repurchases under the 10b5-1 Plan are administered through an independent broker.

SHAREBASED_COMPENSATION

SHARE-BASED COMPENSATION	3 Months Ended
	Sep. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
SHARE-BASED COMPENSATION	'
	NOTE 8. SHARE-BASED COMPENSATION
	As discussed further below, until June 2014 we had two equity compensation plans, the Second Amended and Restated 2004 Stock Option Plan (the “Employee Stock Option Plan”) and the Amended and Restated 2004 Directors’ Stock Option Plan (the “Directors’ Stock Option Plan”) (collectively, the “Stock Option Plans”), pursuant to which (i) options to purchase shares of common stock, or (ii) restricted shares of common stock, could be granted up to an aggregate amount of 1,333,333 common shares, with 1,066,667 and 266,666 shares distributed between the Employee Stock Option Plan and the Directors’ Stock Option Plan, respectively. The Stock Option Plans were substantially similar, providing for a strike price equal to the closing price for a share of our common stock as of the last business day immediately prior to the grant date, vesting periods as determined by the Board for the Employee Stock Option Plan and six months for the Directors’ Stock Option Plan, and terms of up to ten years, subject to forfeit 30 days after the holder ceases to be an employee or 90 days after the holder ceases to be a director, as the case may be. Share-based compensation expense under the Stock Option Plans for the three months ended September 30, 2014 and 2013 was $8,000 and $20,000, respectively.
	Stock Options
	No options were granted during the three months ended September 30, 2014 and 2013.
	As of September 30, 2014, there was an aggregate of $6,000 of unrecognized compensation cost under the Stock Option Plans related to 6,667 non-vested outstanding stock options with a per share weighted average value of $1.98. The unrecognized expense is anticipated to be recognized on a straight-line basis over a weighted average period of 11.5 months. Following is a summary of stock option activity for the three months ended September 30, 2014 and 2013:
		2014						2013
		Number of			Weighted-Average			Number of			Weighted-Average
		Shares			Exercise Price			Shares			Exercise Price
	Outstanding at beginning of period		165,002		$	2.4			292,504		$	2.35
	Options granted		—			—			—			—
	Options exercised		—			—			(804	)		1.8
	Options canceled or expired		(8,334	)		5.58			(97,531	)		2.35
	Outstanding at end of period		156,668		$	2.23			194,169		$	2.36
	Stock Options Exercisable at September 30,		150,001		$	2.26			139,729		$	2.57
	Following is a summary of information regarding options outstanding and options exercisable at September 30, 2014:
			Options Outstanding											Options Exercisable
	Range of			Number			Weighted-Avg.			Weighted-			Aggregate.		Number	Weighted-Avg.		Weighted-		Aggregate.
	Exercise Prices			Outstanding			Remaining			Avg.			Intrinsic		Outstanding	Remaining		Avg.		Intrinsic
							Contractual Life			Exercise			Value			Contractual Life		Exercise		Value
							in Years			Price						in Years		Price
	$0 to 2.50			145,000			6.98		$	1.87		$	59,450		138,333	6.93	$	1.88	$	56,716
	2.5 to 5.00			3,334			2.63			4.38			—		3,334	2.63		4.38		—
	7.51 to 10.00			8,334			1.27			7.65			—		8,334	1.27		7.65		—
	Total			156,668			6.58		$	2.23		$	59,450		150,001	6.52	$	2.26	$	56,716
	In June 2014, our Board of Directors terminated the Employee Stock Option Plan, with the provision that options outstanding under the Employee Stock Option Plan will remain outstanding in accordance with their respective terms. At the date of termination, 531,381 shares were reserved for issuance under the Employee Stock Option Plan in excess of shares issuable pursuant to outstanding options, all of which shares will be available for issuance under the provisions of the Employee Stock Purchase Plan described below.
	In September 2014, our Board approved the inclusion in our proxy statement for approval by our shareholders at the 2014 Annual Meeting of Shareholders its recommendation to terminate the Directors’ Stock Option Plan. At September 30, 2014, 173,334 shares were reserved for issuance under the Directors’ Stock Option Plan, all of which, subject to the aforementioned shareholder approval to terminate the Directors’ Stock Option Plan, will be available for issuance under the provisions of the Employee Stock Purchase Plan described below.
	Employee Stock Purchase Plan
	Also in September 2014, our Board approved the establishment of an Employee Stock Purchase Plan (the “ESPP”). The ESPP conforms to the provisions of Section 423 of the Internal Revenue Code, has coterminous offering and purchase periods of six months, and bases the pricing to purchase shares of our common stock on a formula so as to result in a per share purchase price that approximates a 15% discount from the market price of a share of our common stock at the end of the purchase period. The Board of Directors also approved the provision that shares formerly reserved for issuance under the Employee Stock Option Plan and, subject to shareholder approval described above, the Directors’ Stock Option Plan in excess of shares issuable pursuant to outstanding options, aggregating 704,715 shares, be reserved for issuance pursuant to the ESPP.
	Restricted Stock
	The following is a summary of restricted share activity for the three months ended September 30, 2014 and 2013:
		2014						2013
		Number of			Weighted-			Number of			Weighted-
		Shares			Average			Shares			Average
					Grant Date						Grant Date
					Fair Value						Fair Value
	Outstanding at beginning of period		13,333		$	1.73			32,500		$	1.73
	Granted		—			—			—			—
	Vested		(6,667	)		1.73			(9,166	)		1.73
	Forfeited		—			—			(5,000	)		1.73
	Outstanding at end of period		6,666		$	1.73			18,334		$	1.73
	As of September 30, 2014, there was $8,000 in unrecognized compensation cost related to non-vested outstanding restricted shares. The unrecognized expense is anticipated to be amortized over the next 11.5 months.

MAJOR_CUSTOMERS

MAJOR CUSTOMERS	3 Months Ended
	Sep. 30, 2014
Risks and Uncertainties [Abstract]	'
MAJOR CUSTOMERS	'
	NOTE 9. MAJOR CUSTOMERS
	Information with respect to the only customer (“Customer 1”), that accounted for sales in excess of 10% of our total sales in both the three-month periods ended September 30, 2014 and 2013, is as follows (in thousands, except percentages):
		Three Months Ended September 30,
		2014					2013
		Amount		Percent of			Amount		Percent of
				Total					Total
	Total revenue	$	2,595		100	%	$	2,555		100	%
	Customer concentration:
	Customer 1	$	1,507		58	%	$	1,096		43	%
	Information with respect to Customer 1, accounts receivable from whom comprised more than 10 % of our gross accounts receivable at September 30, 2014 and June 30, 2014, is as follows (in thousands, except percentages):
		30-Sep-14					30-Jun-14
	Total gross accounts receivable	$	1,128		100	%	$	1,805		100	%
	Customer concentration:
	Customer 1.	$	606		54	%	$	962		53	%

COMMITMENTS_AND_CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	3 Months Ended
	Sep. 30, 2014
Commitments and Contingencies Disclosure [Abstract]	'
COMMITMENTS AND CONTINGENCIES	'
	NOTE 10. COMMITMENTS AND CONTINGENCIES
	Legal Matters
	In general, we are from time to time a party to various legal proceedings incidental to our business, none of which we currently consider may be material. There can be no certainty, however, that we may not ultimately incur liability or that such liability will not be material and adverse.

FAIR_VALUE_MEASUREMENTS

FAIR VALUE MEASUREMENTS	3 Months Ended
	Sep. 30, 2014
Fair Value Disclosures [Abstract]	'
FAIR VALUE MEASUREMENTS	'
	NOTE 11. FAIR VALUE MEASUREMENTS
	Fair value is measured based on the prices that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value measurements are based on a three-tier hierarchy that prioritizes the inputs used to measure fair value. These tiers include: Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs for which little or no market data exists, therefore requiring an entity to develop its own assumptions.
	Cash and cash equivalents: The carrying value of cash and cash equivalents is considered to be representative of their fair values based on the short term nature of these instruments. As such, cash and cash equivalents are classified within Level 1 of the valuation hierarchy.
	Investments: Investments consist of marketable equity securities of publicly held companies. As such, investments are classified within Level 1 of the valuation hierarchy.
	Although the methods above may produce a fair value calculation that may not be indicative of the net realizable value or reflective of future fair values, we believe its valuation methods are appropriate.

OTHER_TRANSACTIONS

OTHER TRANSACTIONS	3 Months Ended
	Sep. 30, 2014
Notes to Financial Statements	'
OTHER TRANSACTIONS	'
	NOTE 12. OTHER TRANSACTIONS
	On July 2, 2014, we made an initial deposit in the amount of $10,000 to open an escrow account to facilitate the purchase of substantially all of the assets of a Northern California-based sole proprietorship that is engaged in the manufacture of machined parts, primarily for customers in the oil and electronics industries. The initial deposit was made pursuant to an Asset Purchase Agreement between the parties dated June 20, 2014 (the “Agreement”), which Agreement became effective upon us making the initial deposit. On September 8, 2014, we made a second $10,000 deposit in conformity with the amended terms of the Agreement, which acknowledged that certain due diligence procedures had yet to be completed. The deposits, less escrow costs, are refundable to us if the transaction is not consummated due to a failure of certain closing conditions, including certain due diligence procedures, to be satisfied. The aggregate purchase price for the assets is $225,000 (inclusive of deposit amounts), subject to adjustment as defined in the Agreement. The Company will pay the balance of the purchase price upon consummation of the acquisition, if completed.

SUMMARY_OF_SIGNIFICANT_ACCOUNT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	3 Months Ended
	Sep. 30, 2014
Accounting Policies [Abstract]	'
Recent Accounting Standards	'
	Recent Accounting Standards
	In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2014-09, “Revenue from Contracts with Customers,” which outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. ASU 2014-09 requires an entity to recognize revenue depicting the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. ASU 2014-09 also requires enhanced revenue related disclosures. ASU 2014-09 is effective for fiscal years, and interim reporting periods within those years, beginning after December 15, 2016. The Company has not yet determined the impact of ASU 2014-09 on its consolidated results of operations, financial condition, or cash flows.
	In April 2014, the FASB issued ASU 2014-08, “Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity.” ASU 2014-08 requires that a disposal representing a strategic shift that has (or will have) a major effect on an entity’s financial results or a business activity classified as held for sale should be reported as discontinued operations. ASU 2014-08 also expands the disclosure requirements for discontinued operations and adds new disclosures for individually significant dispositions that do not qualify as discontinued operations. ASU 2014-08 is effective prospectively for fiscal years, and interim reporting periods within those years, beginning after December 15, 2014. The impact of ASU 2014-08 is dependent upon the nature of dispositions, if any, after adoption.
Reclassifications	'
	Reclassifications
	Certain prior period balances have been reclassified to conform to the current period presentation. The reclassifications have no effect on previously reported results of operations or accumulated deficit.

COMPOSITION_OF_CERTAIN_FINANCI1

COMPOSITION OF CERTAIN FINANCIAL STATEMENT ITEMS (Tables)	3 Months Ended
	Sep. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Schedule of inventories	'
	Inventory is stated at the lower of cost (first-in, first-out) or market and consists of the following (in thousands):
		September 30,		June 30,
		2014		2014
	Raw materials /purchased components	$	820	$	878
	Work in process		750		525
	Sub-assemblies /finished components		801		823
	Finished goods		216		374
	Total inventory	$	2,587	$	2,600
Schedule of invesments	'
	Investments are stated at market value and consist of the following (in thousands):
		September 30,		June 30,
		2014		2014
	Marketable equity securities	$	1,082	$	1,058
Schedule of intangibles	'
	Intangibles consist of the following (in thousands):
		September 30,		June 30,
		2014		2014
	Capitalized software development costs	$	73	$	37
	Patent-related costs		92		68
	Total intangibles	$	165	$	105

WARRANTY_Tables

WARRANTY (Tables)	3 Months Ended
	Sep. 30, 2014
Product Warranties Disclosures [Abstract]	'
Schedule of accrual warranty costs	'
	Information regarding the accrual for warranty costs for the three months ended September 30, 2014 and 2013 are as follows (in thousands):
		As of and for the
		Three Months Ended
		September 30,
		2014			2013
	Beginning balance	$	237		$	321
	Accruals during the period		70			49
	Changes in estimates of prior period warranty accruals		(75	)		(36	)
	Warranty amortization		(19	)		(105	)
	Ending balance	$	213		$	229

NET_INCOME_LOSS_PER_SHARE_Tabl

NET INCOME (LOSS) PER SHARE (Tables)	3 Months Ended
	Sep. 30, 2014
Earnings Per Share [Abstract]	'
Schedule of weighted average shares outstanding calculation of basic and diluted per share	'
	In the tables below, income (loss) amounts represent the numerator, and share amounts represent the denominator (in thousands, except per share amounts):
		Three Months Ended
		September 30,
		2014			2013
	Basic:
	Income (loss) from continuing operations	$	(181	)	$	18
	Weighted average shares outstanding		4,209			3,345
	Basic income (loss) per share from continuing operations	$	(0.04	)	$	0
	Income from discontinued operations	$	11		$	194
	Weighted average shares outstanding		4,209			3,345
	Basic income (loss) per share from discontinued operations	$	0		$	0.06
	Net income (loss)	$	(170	)	$	212
	Weighted average shares outstanding		4,209			3,345
	Basic income (loss) per share	$	(0.04	)	$	0.06
	Diluted:
	Income (loss) from continuing operations	$	(181	)	$	18
	Weighted average shares outstanding		4,209			3,345
	Effect of dilutive securities – stock options		—			8
	Weighted average shares used in calculation of diluted earnings per share		4,209			3,353
	Basic and diluted loss per share from continuing operations	$	(0.04	)	$	0
	Income from discontinued operations	$	11		$	194
	Weighted average shares outstanding		4,209			3,345
	Effect of dilutive securities – stock options		—			8
	Weighted average shares used in calculation of diluted earnings per share		4,209			3,353
	Diluted income per share from discontinued operations	$	0		$	0.06
	Net income (loss)	$	(170	)	$	212
	Weighted average shares used in calculation of diluted earnings per share		4,209			3,353
	Diluted earnings (loss) per share	$	(0.04	)	$	0.06

DISCONTINUED_OPERATIONS_AND_RE1

DISCONTINUED OPERATIONS AND REAL ESTATE HELD FOR SALE (Tables)	3 Months Ended
	Sep. 30, 2014
Discontinued Operations and Disposal Groups [Abstract]	'
Schedule of revenue and operating results of Astromec	'
	Information regarding revenue and operating results of Astromec included in discontinued operations is as follows (in thousands):
		Three Months Ended
		September 30,
		2014		2013
	Revenues	$	21	$	29
	Income before provision for income taxes of $7,000 and $0, respectively	$	18	$	194
Schedule of Astromec assets and liabilities	'
	Information regarding Astromec assets and liabilities included in the accompanying consolidated balance sheets is as follows (in thousands):
		September 30,		June 30,
		2014		2014
	Accounts receivable	$	21	$	17
	Prepaid expenses	$	—	$	3
	Accrued expenses	$	2	$	2

IINCOME_TAXES_Tables

IINCOME TAXES (Tables)	3 Months Ended
	Sep. 30, 2014
Income Tax Disclosure [Abstract]	'
Schedule of accrual unrecognized tax benefits	'
	A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows (in thousands):
	Balance at July 1, 2014	$	363
	Additions based on tax positions related to the current year		3
	Balance at September 30, 2014	$	366

SHAREBASED_COMPENSATION_Tables

SHARE-BASED COMPENSATION (Tables)	3 Months Ended
	Sep. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Schedule of summary of stock option activity	'
	Following is a summary of stock option activity for the three months ended September 30, 2014 and 2013:
		2014						2013
		Number of			Weighted-Average			Number of			Weighted-Average
		Shares			Exercise Price			Shares			Exercise Price
	Outstanding at beginning of period		165,002		$	2.4			292,504		$	2.35
	Options granted		—			—			—			—
	Options exercised		—			—			(804	)		1.8
	Options canceled or expired		(8,334	)		5.58			(97,531	)		2.35
	Outstanding at end of period		156,668		$	2.23			194,169		$	2.36
	Stock Options Exercisable at September 30,		150,001		$	2.26			139,729		$	2.57
Schedule of options outstanding and options exercisable	'
	Following is a summary of information regarding options outstanding and options exercisable at September 30, 2014:
			Options Outstanding											Options Exercisable
	Range of		Number			Weighted-Avg.			Weighted-			Aggregate.		Number		Weighted-Avg.		Weighted-		Aggregate.
	Exercise Prices		Outstanding			Remaining			Avg.			Intrinsic		Outstanding		Remaining		Avg.		Intrinsic
						Contractual Life			Exercise			Value				Contractual Life		Exercise		Value
						in Years			Price							in Years		Price
	$0 to 2.50			145,000			6.98		$	1.87		$	59,450		138,333		6.93	$	1.88	$	56,716
	2.5 to 5.00			3,334			2.63			4.38			—		3,334		2.63		4.38		—
	7.51 to 10.00			8,334			1.27			7.65			—		8,334		1.27		7.65		—
	Total			156,668			6.58		$	2.23		$	59,450		150,001		6.52	$	2.26	$	56,716
Schedule of restricted share activity	'
	The following is a summary of restricted share activity for the three months ended September 30, 2014 and 2013:
		2014						2013
		Number of			Weighted-			Number of			Weighted-
		Shares			Average			Shares			Average
					Grant Date						Grant Date
					Fair Value						Fair Value
	Outstanding at beginning of period		13,333		$	1.73			32,500		$	1.73
	Granted		—			—			—			—
	Vested		(6,667	)		1.73			(9,166	)		1.73
	Forfeited		—			—			(5,000	)		1.73
	Outstanding at end of period		6,666		$	1.73			18,334		$	1.73

MAJOR_CUSTOMERS_Tables

MAJOR CUSTOMERS (Tables)	3 Months Ended
	Sep. 30, 2014
Risks and Uncertainties [Abstract]	'
Schedule of sales by major customers	'
	Information with respect to the only customer (“Customer 1”), that accounted for sales in excess of 10% of our total sales in both the three-month periods ended September 30, 2014 and 2013, is as follows (in thousands, except percentages):
		Three Months Ended September 30,
		2014					2013
		Amount		Percent of			Amount		Percent of
				Total					Total
	Total revenue	$	2,595		100	%	$	2,555		100	%
	Customer concentration:
	Customer 1	$	1,507		58	%	$	1,096		43	%
	Information with respect to Customer 1, accounts receivable from whom comprised more than 10 % of our gross accounts receivable at September 30, 2014 and June 30, 2014, is as follows (in thousands, except percentages):
		30-Sep-14					30-Jun-14
	Total gross accounts receivable	$	1,128		100	%	$	1,805		100	%
	Customer concentration:
	Customer 1.	$	606		54	%	$	962		53	%

COMPOSITION_OF_CERTAIN_FINANCI2

COMPOSITION OF CERTAIN FINANCIAL STATEMENT ITEMS (Details) (USD $)	Sep. 30, 2014	Jun. 30, 2014
In Thousands, unless otherwise specified
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'	'
Raw materials / purchased components	$820	$878
Work in process	750	525
Sub-assemblies / finished components	801	823
Finished goods	216	374
Total inventory	$2,587	$2,600

COMPOSITION_OF_CERTAIN_FINANCI3

COMPOSITION OF CERTAIN FINANCIAL STATEMENT ITEMS (Details 2) (USD $)	Sep. 30, 2014	Jun. 30, 2014
In Thousands, unless otherwise specified
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'	'
Marketable equity securities	$1,082	$1,058

COMPOSITION_OF_CERTAIN_FINANCI4

COMPOSITION OF CERTAIN FINANCIAL STATEMENT ITEMS (Details 3) (USD $)	Sep. 30, 2014	Jun. 30, 2014
In Thousands, unless otherwise specified
Finite-Lived Intangible Assets [Line Items]	'	'
Intangible assets,net	$165	$105
Capitalized software development costs	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Intangible assets,net	73	37
Patent-related costs	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Intangible assets,net	$92	$68

COMPOSITION_OF_CERTAIN_FINANCI5

COMPOSITION OF CERTAIN FINANCIAL STATEMENT ITEMS (Details Textuals) (USD $)	3 Months Ended	12 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Jun. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'	'
Marketable security cost	$869	$857
Marketable security unrealized, gain	231	208
Marketable security unrealized, loss	$18	$7

WARRANTY_Details

WARRANTY (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013
Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward]	'	'
Beginning balance	$237	$321
Accruals during the period	70	49
Changes in estimates of prior period warranty accruals	-75	-36
Warranty amortization	-19	-105
Ending balance	$213	$229

WARRANTY_Details_Textuals

WARRANTY (Details Textuals) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Product Warranties Disclosures [Abstract]	'	'	'	'
Warranty reserve	$213	$229	$237	$321
Warranty expenses	($5)	$13	'	'

NET_INCOME_LOSS_PER_SHARE_Deta

NET INCOME (LOSS) PER SHARE (Details) (USD $)	3 Months Ended
In Thousands, except Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013
Basic:	'	'
Income (loss) from continuing operations	($181)	$18
Weighted average shares outstanding	4,209	3,345
Basic income (loss) per share from continuing operations	($0.04)	$0
Income from discontinued operations	11	194
Weighted average shares outstanding	4,209	3,345
Basic income (loss) per share from discontinued operations	$0	$0.06
Net income (loss)	($170)	$212
Weighted average shares outstanding	4,209	3,345
Basic income (loss) per share	($0.04)	$0.06
Diluted:	'	'
Effect of dilutive securities - stock options	'	8
Weighted average shares used in calculation of diluted earnings per share	4,227,650	3,353,447
Basic and diluted loss per share from continuing operations	($0.04)	$0
Diluted income per share from discontinued operations	$0	$0.06
Diluted earnings (loss) per share	($0.04)	$0.06

NET_INCOME_LOSS_PER_SHARE_Deta1

NET INCOME (LOSS) PER SHARE (Details Textuals)	3 Months Ended
	Sep. 30, 2014
Earnings Per Share [Abstract]	'
Number of anti-dilutive securities	18,693

DISCONTINUED_OPERATIONS_AND_RE2

DISCONTINUED OPERATIONS AND REAL ESTATE HELD FOR SALE (Details) (Astromec, USD $)	3 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013
Astromec	'	'
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]	'	'
Revenues	$21	$29
Income before provision for income taxes of $7,000 and $0, respectively	18	194
Tax effect	$7	$0

DISCONTINUED_OPERATIONS_AND_RE3

DISCONTINUED OPERATIONS AND REAL ESTATE HELD FOR SALE (Details 2) (Astromec, USD $)	Sep. 30, 2014	Jun. 30, 2014
In Thousands, unless otherwise specified
Astromec	'	'
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]	'	'
Accounts receivable	$21	$17
Prepaid expenses	'	3
Accrued expenses	$2	$2

DISCONTINUED_OPERATIONS_AND_RE4

DISCONTINUED OPERATIONS AND REAL ESTATE HELD FOR SALE (Details Textuals) (USD $)	Jun. 30, 2013	Jul. 05, 2013	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014
In Thousands, unless otherwise specified		Aesthetic and Reconstructive Technologies, Inc.	Astromec	Astromec	Astromec
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]	'	'	'	'	'
Earnout payments period	'	'	'30 days	'	'
Percentage of earnout payments in first year	'	'	6.00%	'	'
Percentage of earnout payments in second year	'	'	4.00%	'	'
Percentage of earnout payments in third year	'	'	2.00%	'	'
Income from earnout payments	'	'	$21	$29	$372
Real estate held for sale	733	'	'	'	'
Proceeds from sale of real estate held for sale	'	980	'	'	'
Net proceeds from the sale	'	900	'	'	'
Broker commissions and fees	'	80	'	'	'
Gain on sale of property	'	$167	'	'	'

INCOME_TAXES_Details

INCOME TAXES (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]	'
Beginning Balance	$363
Additions based on tax positions related to the current year	3
Ending Balance	$366

INCOME_TAXES_Details_Textuals

INCOME TAXES (Details Textuals) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Jun. 30, 2014
Income Tax Disclosure [Abstract]	'	'
Deferred tax assets, Valuation allowance	'	$3,500
Accrued unrecognized tax benefits related to federal and state income tax	366	'
Decrease in income tax expenses	$47	'

COMMON_STOCK_Details_Textuals

COMMON STOCK (Details Textuals) (USD $)	3 Months Ended
In Thousands, except Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013
Maximum number of shares authorized to be repurchased (in shares)	'	750,000
Number of shares repurchsed	7,665	'
Value of shares reourchased	$17	'
Right offering	'	'
Subscription Price (in dollars per share)	$1.90	'
Proceeds from issuance of common stock	1,650	'
Estimated offering expenses	$140	'
Common stock shareholder subscription	868,732	'
Right offering | AO Partners	'	'
Number of rights issued (in shares)	317,231	'
Right offering | Farnam Street Partners	'	'
Number of rights issued (in shares)	156,189	'

SHAREBASED_COMPENSATION_Detail

SHARE-BASED COMPENSATION (Details) (USD $)	3 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]	'	'
Outstanding at beginning of period	165,002	292,504
Options granted	'	'
Options exercised	'	-804
Options canceled or expired	-8,334	-97,531
Outstanding at end of period	156,668	194,169
Exercisable at end of period	150,001	139,729
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]	'	'
Outstanding at beginning of period	$2.40	$2.35
Options granted	'	'
Options exercised	'	$1.80
Options canceled or expired	$5.58	$2.35
Outstanding at end of period	$2.23	$2.36
Exercisable at end of period	$2.26	$2.57

SHAREBASED_COMPENSATION_Detail1

SHARE-BASED COMPENSATION (Details 2) (USD $)	3 Months Ended
In Thousands, except Share data, unless otherwise specified	Sep. 30, 2014
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Number Outstanding	156,668
Weighted-Average Remaining Contractual Life	'6 years 6 months 29 days
Weighted-Average Exercise Price	$2.23
Aggregate Intrinsic Value	$59,450
Number Outstanding	150,001
Weighted-Average Remaining Contractual Life	'6 years 6 months 7 days
Weighted-Average Exercise Price	$2.26
Aggregate Intrinsic Value	56,716
$0 to $2.50	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Number Outstanding	145,000
Weighted-Average Remaining Contractual Life	'6 years 11 months 23 days
Weighted-Average Exercise Price	$1.87
Aggregate Intrinsic Value	59,450
Number Outstanding	138,333
Weighted-Average Remaining Contractual Life	'6 years 11 months 5 days
Weighted-Average Exercise Price	$1.88
Aggregate Intrinsic Value	56,716
$2.5 to $5.50	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Number Outstanding	3,334
Weighted-Average Remaining Contractual Life	'2 years 7 months 17 days
Weighted-Average Exercise Price	$4.38
Aggregate Intrinsic Value	'
Number Outstanding	3,334
Weighted-Average Remaining Contractual Life	'2 years 7 months 17 days
Weighted-Average Exercise Price	$4.38
Aggregate Intrinsic Value	'
$7.51 to $10.0	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Number Outstanding	8,334
Weighted-Average Remaining Contractual Life	'1 year 3 months 7 days
Weighted-Average Exercise Price	$7.65
Aggregate Intrinsic Value	'
Number Outstanding	8,334
Weighted-Average Remaining Contractual Life	'1 year 3 months 7 days
Weighted-Average Exercise Price	$7.65
Aggregate Intrinsic Value	'

SHAREBASED_COMPENSATION_Detail2

SHARE-BASED COMPENSATION (Details 3) (Restricted shares, USD $)	3 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Restricted shares	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]	'	'
Outstanding at beginning of year	13,333	32,500
Granted	'	'
Vested	-6,667	-9,166
Forfeited	'	-5,000
Outstanding at end of period	6,666	18,334
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]	'	'
Outstanding at beginning of year	$1.73	$1.73
Granted	'	'
Vested	$1.73	$1.73
Forfeited	'	$1.73
Outstanding at end of period	$1.73	$1.73

SHAREBASED_COMPENSATION_Detail3

SHARE-BASED COMPENSATION (Details Textuals) (USD $)	3 Months Ended
In Thousands, except Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Allocated share-based compensation expense	$8	$20
Unrecognized compensation cost	6	'
Number of nonvested stock options	6,667	'
Weighted average value of non vested stock options (in dollars per share)	$1.98	'
Unrecognized expensse recognized weighted average period	'11 months 15 days	'
Employees Stock Option Plan	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Number of shares reserved for future issuance	531,381	'
Directors Stock Option Plan	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Number of shares reserved for future issuance	173,334	'
ESPP	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Number of shares reserved for future issuance	704,715	'
Description of plan	'	'
	Offering and purchase periods of six months, and bases the pricing to purchase shares of our common stock on a formula so as to result in a per share purchase price that approximates a 15% discount from the market price of a share of our common stock at the end of the purchase period.
Restricted shares	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Number of shares authorized	1,333,333	'
Description of vesting period	'	'
	Vesting periods as determined by the Board for the Employee Stock Option Plan and six months for the Directors’ Stock Option Plan, and terms of up to ten years, subject to forfeit 30 days after the holder ceases to be an employee or 90 days after the holder ceases to be a director, as the case may be.
Unrecognized expensse recognized weighted average period	'11 months 15 days	'
Unrecognized compensation cost	$8	'
Restricted shares | Employees Stock Option Plan	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Number of shares authorized	1,066,667	'
Forfeiture period of stock option in case of cessation of employment	'30 days	'
Restricted shares | Directors Stock Option Plan	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Number of shares authorized	266,666	'
Forfeiture period of stock option in case of cessation of employment	'90 days	'

MAJOR_CUSTOMERS_Details

MAJOR CUSTOMERS (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Jun. 30, 2014	Sep. 30, 2014	Jun. 30, 2014
		Sales	Sales	Sales	Sales	Accounts Receivable	Accounts Receivable	Accounts Receivable	Accounts Receivable
				Customer 1	Customer 1			Customer 1	Customer 1
Sales	'	$2,595	$2,555	$1,507	$1,096	'	'	'	'
Percentage of sales concentrations risk	10.00%	100.00%	100.00%	58.00%	43.00%	'	'	'	'
Accounts Receivable	'	'	'	'	'	$1,128	$1,805	$606	$962
Percentage of total accounts receivable	'	'	'	'	'	100.00%	100.00%	54.00%	53.00%

MAJOR_CUSTOMERS_Details_Textua

MAJOR CUSTOMERS (Details Textuals)	3 Months Ended
	Sep. 30, 2014
Risks and Uncertainties [Abstract]	'
Percentage of sales concentrations risk	10.00%

OTHER_TRANSACTIONS_Details_Tex

OTHER TRANSACTIONS (Details Textuals) (Asset Purchase Agreement, USD $)	Sep. 30, 2014	Sep. 08, 2014	Jul. 02, 2014
In Thousands, unless otherwise specified
Asset Purchase Agreement	'	'	'
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]	'	'	'
Amount deposited in escrow account	'	$10	$10
Aggregate purchase price	$225	'	'